Mammography

A recent advisory by the FDA urging breast imaging facilities to ensure compatibility between full-field digital mammography systems and PACS exposed an ongoing problem: Interoperability issues persist as some vendors fail to comply with healthcare digital imaging standards.

FDG-PET/CT's power for staging and restaging breast cancer is attracting attention. It could also detect recurrence in more than two-thirds of these patients and change the management plan in up to a third, according to German investigators.

The FDA is considering a national registry for thermal ablation treatment of breast cancer. The proposed registry would compile information on all thermal ablation devices and therapies for small carcinomas and address inconsistencies that potentially diminish the value of previously published feasibility protocols.

PACS may obscure FFDM dataSiemens reports 3Q growthVelocity updates treatment planningItaly sets CT colonography project

Women with diagnostic mammograms flagged as probably benign usually undergo short-interval follow-up. But at 12 months, this second look may not boost cancer detection.

It is a safe bet that conventional mammography will give way to 3D imaging and other advanced technologies in the not-too-distant future. The gamble lies in picking which technology will emerge the clear winner as the primary screening tool for breast cancer: digital breast tomosynthesis or dedicated breast CT.

Now that computer-aided detection has become part of routine clinical work for cancer screening in mammograms and is being applied in the differential diagnosis of cancer in the lung and colon, it's only a matter of time before it rates as the standard of care for diagnostic examinations in daily clinical work.

Temporal subtractions and nodule detection are the most common computer-aided detection systems available. Until recently, however, no report has described these CAD routines being integrated into PACS.

The rate of decline in breast cancer rates over the past decade has been smaller among African American women than the general population, despite improved screening techniques.

Groundbreaking research has confirmed that Pittsburgh Compound B binds to the beta-amyloid deposits in the brains of patients with Alzheimer's disease. The finding is a major step toward an early, definitive diagnosis of the memory-stealing condition.

The feasibility of hub-and-spoke mammography, in which breast imaging studies are performed at satellite centers and read at a centralized reading station, has been confirmed through an evaluation of 30,000 cases and three years of clinical experience. The Columbia University study finds the transmission and interpretation of digital mammography exams to and from a remote location through commercially available high-speed cable Internet access is safe, reliable, and cost-effective.

A national registry for thermal ablation treatment for breast cancer is under consideration by the FDA. The agency opened a six-month public comment period this week on the proposed registry, which would compile information on all thermal ablation devices and therapies for small carcinomas.

FDA moves to ease digital mammography regulation Software firm reaches into IRRadNet falls short on vote to reincorporateACR taps Thrall as chair, names other officers

omputer-aided detection and diag-nosis tools were showcased at the European Congress of Radiology's "ESR meets Germany" session. Speakers highlighted four key clinical areas where advances could make a real difference to diagnostic decision making.

Aquilion steps out in Vegas NightHawk profits down, plans stock buybackThin-client firm readies 3D for SIIM meetingVolcano revenues riseMRS firm releases mammography software

Excitement is never in short supply in Las Vegas. But a new session at the 2008 Stanford International Multidetector-Row CT Symposium may give the casinos, cocktail lounges, and Canadian circus acts a run for their money.

GE plans Brazilian X-ray plant Hologic snags multiple FFDM order Hologic partners with MindrayMedrad prepares educational program for ISMRMNightHawk Radiology returns to Nasdaq compliance

Computer-aided detection may lend an extra punch to the diagnosis of pulmonary embolism with multislice and dual-energy CT scanners. Studies by French and German researchers have shown it helps detect small, hard-to-spot clots lodged in the lungs' periphery.

A clinical study to determine computer-aided detection’s value to CT colonography could save manufacturers time and money by speeding up the regulatory approval process. If proven successful, the approach could save thousands of lives each year by enhancing early colorectal cancer detection.

Computer-aided detection schemes for breast MR imaging have shown plenty of promise, but they always fall short of full automation and lesion characterization. Two recent studies, however, suggest CAD for breast MRI may be closing in on true cancer detection.

What’s happening with the American Roentgen Ray Society? Its annual meeting, known mainly for the quality of its refresher course, has become an essential point of coverage for world-class scientific research as well.

Nearly 30,000 cases and three years of experience have confirmed that the transmission and interpretation of digital mammography exams to and from a remote location through commercially available high-speed cable Internet access is feasible, safe, reliable, and cost-effective, according to a Columbia University study.

Quest prepares 12-Bit mammo display Connect Imaging releases CRm fixAbbott analyzer enters Medrad portfolio

Philips partners with Chinese hospitalSiemens signs Cleveland Clinic to cardiovascular systems dealCarestream supplies digitizer to Siemens

Toshiba upgrades CT productivity at ACCMerge battles for survivalHologic shares split

Method shows higher sensitivity, recall rate than single interpretation but lower recall rate than double reading

GE unveils new CV ultrasound unitMcKesson enhances Horizon CardiologyPhilips boosts stent placementFuji meets U.S. mammography milestone

The always-controversial International Early Lung Cancer Action Program has been struck a serious blow with news that the trial was funded by a cigarette manufacturer, according to an article in Wednesday’s New York Times.

Product sales increase during unprofitable year for CytogenFDA announces MQSA enforcement actions

The director of the FDA’s Office of Device Evaluation has informed iCAD that the agency will approve its SecondLook Digital computer-aided detection software for use on Fujifilm’s computed radiography mammography system (CRm), according to Ken Ferry, president and CEO of the company. iCAD has spent 20 months seeking FDA approval for the software.